Ovid Therapeutics (OVID) Other Accumulated Expenses (2016 - 2022)
Ovid Therapeutics (OVID) posted Other Accumulated Expenses of $139167.0 for Q1 2022, down 74.53% on a QoQ basis from $546464.0 in Q4 2021, and down 79.33% year-over-year from $673285.0 in Q1 2021.
Ovid Therapeutics (OVID) Other Accumulated Expenses (2016 - 2022) Analysis & Trends
Ovid Therapeutics' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $139167.0 for Q1 2022.
- Quarterly Other Accumulated Expenses fell 79.33% year-over-year to $139167.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $139167.0 (down 79.33% YoY) and the FY2021 annual result came in at $546464.0, up 230.12% from the prior year.
- Other Accumulated Expenses was $139167.0 for Q1 2022 at Ovid Therapeutics, down from $546464.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.0 million in Q2 2021 and bottomed at $119940.0 in Q3 2021.
- A 5-year average of $342914.5 and a median of $184923.0 in 2018 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 621.03% — and 2022, when it tumbled 79.33%.
- Ovid Therapeutics' Other Accumulated Expenses stood at $184923.0 in 2018, then rose by 25.51% to $232095.0 in 2019, then dropped by 28.68% to $165536.0 in 2020, then surged by 230.12% to $546464.0 in 2021, then sank by 74.53% to $139167.0 in 2022.
- Business Quant data shows OVID's Other Accumulated Expenses at $139167.0 in Q1 2022, $546464.0 in Q4 2021, and $119940.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 139,167.00 |
| Dec 31, 2021 | 546,464.00 |
| Sep 30, 2021 | 119,940.00 |
| Jun 30, 2021 | 1.96 Mn |
| Mar 31, 2021 | 673,285.00 |
| Dec 31, 2020 | 165,536.00 |
| Sep 30, 2020 | 274,903.00 |
| Jun 30, 2020 | 271,314.00 |
| Mar 31, 2020 | 248,813.00 |
| Dec 31, 2019 | 232,095.00 |
| Sep 30, 2019 | 236,716.00 |
| Jun 30, 2019 | 168,798.00 |
| Mar 31, 2019 | 148,414.00 |
| Dec 31, 2018 | 184,923.00 |
| Sep 30, 2018 | 169,347.00 |
| Jun 30, 2018 | 142,796.00 |
| Mar 31, 2018 | 150,768.00 |
| Dec 31, 2017 | 246,503.00 |
| Sep 30, 2017 | 157,015.00 |
| Jun 30, 2017 | 124,320.00 |